Market Newsdesk

BEIJING, April 10, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today published its 2024 Environmental, Social and Governance (“ESG”) report (“the report”), reaffirming the Company’s unwavering commitment to fostering a responsible and sustainable online recruitment platform that empowers job seekers, supports business development, and generates long-term societal value.

The report outlines the Company’s achievements and impacts across seven key ESG dimensions: ESG governance, products and services optimization, employee growth, green development, sustainable supply chain practices, community engagement, and standardized corporate governance, cultivating an ecosystem where opportunity, equity, and innovation thrive. By embedding sustainability into its core operations, the Company is dedicated to delivering lasting value to users, stakeholders, and society as a whole.

To access the full report, please visit the Sustainability section of the Company’s investor relations website at https://ir.zhipin.com.

About KANZHUN LIMITED

KANZHUN LIMITED operates the leading online recruitment platform BOSS Zhipin in China. The Company connects job seekers and enterprise users in an efficient and seamless manner through its highly interactive mobile app, a transformative product that promotes two-way communication, focuses on intelligent recommendations, and creates new scenarios in the online recruiting process. Benefiting from its large and diverse user base, BOSS Zhipin has developed powerful network effects to deliver higher recruitment efficiency and drive rapid expansion.

For investor and media inquiries, please contact:

KANZHUN LIMITED
Investor Relations
Email: [email protected]

PIACENTE FINANCIAL COMMUNICATIONS
Email: [email protected]

Bakersfield, CA, April 10, 2025 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: TPET) (“Trio” or the “Company”), a California-based oil and gas company, today is pleased to announce that it has closed on certain petroleum and natural gas properties held by Novacor Exploration Ltd. (“Novacor”). More specifically, TPET closed on Novacor’s TWP48 Assets which is expected to be shortly followed by the closing on Novacor’s TWP47 assets. These assets are in the prolific Lloydminster, Saskatchewan heavy oil region (the “Acquisition”). This acquisition could strategically position the Company to expand its operations into one of North America’s most promising heavy oil basins, with upside potential for long term production and reserve growth. Since the Novacor assets are in the heavy oil area, they offer economic development and low operational costs. Market accessibility combined with a favorable regulatory process makes this area very attractive for continued and future development within these lands.

As reported by the Company’s press release on December 19, 2024, the Novacor assets are located at the South-West quarter of Section 19, Township 47, Range 26W3M and the Northeast Section 3, Township 48, Range 24W3M, both in the Lloydminster, Saskatchewan area. There are currently seven producing wells located on the two properties. Production from the wells in Section 19 is subject to Freehold Royalties of 13.5% and a GORR of 2%, and production from the wells in Section 3 is subject to Freehold Royalties of 15%. The wells produce heavy crude oil from the McLaren/Sparky and Lloydminster formation(s). Novacor is the operator of these cash flow positive wells. Current production is approximately 70 barrels per day with potential for 4 additional re-entry wells and two fully equipped locations to be reactivated each capable of an additional 70 barrels in total per day. All the foregoing information was derived from reports provided to the Company by Novacor.

Additionally, a Reserve Report was prepared in August 2024 by Petrotech and Associates detailing 91.5MBBL for total proved and probable oil of those wells currently being produced. Novacor has identified further potential upside in the Sparky GP thru some multi-lateral drill opportunities.

Important in this acquisition is Novacor’s ability to address recent fluctuations in global oil prices and their limited impact on the company’s operations. Novacor will continue as operator of the assets Trio is acquiring. While market volatility is inherent in the energy sector, Novacor’s strategic focus on operational efficiency and low lift costs provides a significant buffer against downward price pressures.

Novacor’s current lift cost stands at a competitive CDN $10.00 per barrel. This low operational expenditure will help ensure Trio maintains strong profitability even in a lower oil price environment. Their commitment to cost management and efficient production techniques will allow the Company to navigate market fluctuations with greater resilience compared to companies with higher operating costs.

Commented Robin Ross, Chief Executive Officer of Trio, “Novacor has always prioritized operational excellence and fiscal responsibility as their low lift costs are a testament to this commitment and will provide us with a significant advantage in the current market. While we are mindful of global economic trends and their potential influence on commodity prices, our fundamental strength moving forward will be in our ability to produce oil economically.

 As i mentioned previously, we are excited to acquire an initial footprint in this very lucrative oil and gas area of Canada and home to some of the largest players in the industry such as Cenovus Energy, Canadian Natural Resources, Baytex Energy, Rife Resources and many others who have made Heavy Oil a staple of their operation, and where numerous opportunities to acquire additional highly economic fields exist. Trio’s relationship with Novacor is very important, because Novacor has a long history of oil and gas development in the area. Trio’s plan is to aggressively grow its footprint in the area utilizing Novacor as an operator of the assets. We are looking forward to a long and prosperous relationship with Novacor. We will continue to seek opportunities for strategic growth and optimization with Novacor’s operational efficiencies and are confident to deliver consistent value to our shareholders through a disciplined approach to operations and cost management.”

Mr. Ross continued, “Our focus remains on acquiring projects that generate immediate cash flow or offer transformative growth potential with strategic investment. We believe that this approach aligns with our long-term vision of creating exponential value while managing risk and resources effectively.” 

Terms of the Acquisition

The stated purchase price of the Acquisition is US$650,000 in cash paid in two tranches, and 526,536 in shares of common stock of Trio, which we agree to use our commercially reasonable efforts to register for resale in a registration statement filed with the United States Securities and Exchange Commission. The Company paid Novacor a good faith deposit of $65,000, which is being applied to the cash portion of the purchase price on the initial closing.

About Trio Petroleum Corp

Trio Petroleum Corp is an oil and gas exploration and development company in California, Utah, and Saskatchewan, Canada.

Cautionary Statement Regarding Forward-Looking Statements

All statements in this press release of Trio Petroleum Corp (“Trio”) and its representatives and partners that are not based on historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Acts”). In particular, when used in the preceding discussion, the words “estimates,” “believes,” “hopes,” “expects,” “intends,” “on-track”, “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Acts and are subject to the safe harbor created by the Acts. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of the Trio’s control, that could cause actual results to materially and adversely differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth in the Risk Factors sections of the Trio reports filed with the Securities and Exchange Commission (SEC). Copies of such documents are available on the SEC’s website, www.sec.gov . Trio undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Relations Contact:

Redwood Empire Financial Communications
Michael Bayes
(404) 809 4172
[email protected] 

PHILADELPHIA, April 10, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Kenvue Inc. (NYSE: KVUE) on behalf of the company’s long-term investors.

Click here for additional information:



https://kaskelalaw.com/case/kenvue/

Recently a securities fraud complaint was filed against Kenvue on behalf of investors who purchased or acquired shares of the company’s stock between May 8, 2023 and September 12, 2023.

According to the complaint, in connection with the company’s May 8, 2023 initial public offering (“IPO”) of common stock to investors, Kenvue and certain of the company’s senior executive officers (i) made misleading statements and (ii) failed to disclose the material risks that Kenvue was facing with respect to pending regulatory proceedings before the FDA and its advisory panel to reconsider the effectiveness of orally administered phenylephrine (“oral PE”).

As further detailed in the complaint, in September 2023, the Nonprescription Drugs Advisory Committee (“NDAC”) of the U.S. Food and Drug Administration (“FDA”) met to provide its insight and opinions as to the issue of whether oral PE is efficacious as a nasal decongestant, and whether oral PE should be reclassified as not Generally Recognized as Safe and Effective (“GRASE”) due to lack of efficacy. At the conclusion of the meeting, the voting members of the NDAC panel voted unanimously that the current scientific data does not support the conclusion that oral PE is effective as a nasal decongestant, with one member of the panel stating that there was “compelling, convincing evidence that oral phenylephrine is ineffective at relieving symptoms of nasal congestion.” Following the report that the NDAC had unanimously voted that oral PE was not effective, Kenvue’s share price fell by $1.01 per share, or over 4.5% in value.

The investigation seeks to determine whether the members of Kenvue’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.

Kenvue shareholders who purchased or acquired their KVUE shares



prior to September 12, 2023



are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/kenvue/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC

D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly growing Smart Energy Management (SEM) sector. This move follows the successful acquisition of DeepSolar, a cutting-edge provider of AI-driven software solutions designed to optimize solar energy usage in residential and utility-scale solar power plants.

This strategic expansion marks an important milestone in PainReform’s long-term diversification strategy, aimed at tapping into high-growth, tech-enabled markets. With global solar capacity accelerating amid increasing demand for decentralized, sustainable energy solutions, the ability to measure, analyze, and improve solar energy yield is more critical than ever. Optimization software has emerged as a foundational tool in this transition—driving both economic and environmental value for consumers and enterprises alike.

DeepSolar’s product, MyDeepSolar, is an application that leverages machine learning and predictive analytics to provide real-time monitoring, yield forecasting, and performance optimization for solar-enabled homes.

The app helps maximize the return on solar investments and optimize energy efficiency, by providing homeowners with comprehensive insights into their solar system’s performance. It also provides full visibility of the system’s status and losses, allowing users to compare actual energy production with the system’s potential.

“Our expansion into Smart Energy Management not only aligns with global energy trends but also capitalizes on a technology platform with enormous commercial scalability,” said Ehud Geller, Chairman and interim CEO of PainReform. “We believe DeepSolar has the potential to play a transformative role in a market where intelligent optimization is the key to unlocking the full value of solar energy. The future of energy is decentralized, intelligent, and consumer-empowered—and we intend to be at the forefront of that evolution.”

PainReform’s entry into the SEM market comes amid a flurry of M&A activity and institutional investments in solar and smart energy technologies. Governments worldwide are also ramping up support for residential optimization through tax credits, net metering incentives, and smart grid infrastructure.

By entering a sector with strong macro tailwinds, PainReform is expanding its innovation footprint beyond its pharmaceutical roots, leveraging its AI expertise to address new verticals where data-centric platforms drive recurring revenue and operational scalability.

About PainReform

PainReform Ltd. (Nasdaq: PRFX) is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company’s pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide prolonged post-surgical pain relief while minimizing the need for repeated dosing and reducing reliance on opioids. Through DeepSolar, PainReform also delivers advanced software solutions that enable both consumers and enterprises to monitor, forecast, and optimize energy consumption—particularly in solar-integrated environments. This dual business model reflects PainReform’s strategic commitment to applying precision technology across high-impact sectors including healthcare and sustainable energy. For more information, please visit www.painreform.com.

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements about PainReform’s expectations, beliefs and intentions including with respect to the anticipated benefits to PainReform of the acquisition of DeepSolar, the anticipated market opportunity and potential for revenue growth. Forward-looking statements can be identified by the use of forward-looking words such as “believe”, “expect”, “intend”, “plan”, “may”, “should”, “could”, “might”, “seek”, “target”, “will”, “project”, “forecast”, “continue” or “anticipate” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward- looking statements, including, but not limited to, the following: our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our initial product candidate, PRF-110 and the commercialization of the DeepSolar solution; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110 and future product candidates; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; our ability to maintain our listing on the Nasdaq Capital Market; and statements as to the impact of the political and security situation in Israel on our business, including due to the current war in Israel. More detailed information about the risks and uncertainties affecting us is contained under the heading “Risk Factors” included in the Company’s most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future.

Contact:

Crescendo Communications, LLC
Tel: 212-671-1021
Email: [email protected]

Dr. Ehud Geller
Chairman and interim Chief Executive Officer
PainReform Ltd.
Tel: +972-54-4236711
Email: [email protected]

BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) — Netcapital Inc. (Nasdaq: NCPL, NCPLW) (the “Company”), a digital private capital markets ecosystem, today announced that graphene-licensing technology company, Avadain, raised more than $1.275 million within the first 24 hours of launching its third offering on the Netcapital funding portal platform.

Avadain’s offering is available for a limited time on Netcapital.com. Investors can review offering details, risks, and disclosures by visiting https://netcapital.com/companies/avadain.

About Avadain

Avadain is a Tennessee-based company with a globally patented technology to manufacture the type of graphene that it believes can be used as an additive material in thousands of applications across leading growth industries.

About Netcapital Inc.

Netcapital Inc.
is a fintech company with a scalable technology platform that allows private companies to raise capital online and provides private equity investment opportunities to investors. The Company’s consulting group, Netcapital Advisors, provides marketing and strategic advice and takes equity positions in select companies. The Company’s funding portal, Netcapital Funding Portal, Inc. is registered with the U.S. Securities & Exchange Commission (SEC) and is a member of the Financial Industry Regulatory Authority (FINRA), a registered national securities association. The Company’s broker-dealer, Netcapital Securities Inc., is also registered with the SEC and is a member of FINRA.

Forward Looking Statements

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Investor Contact

800-460-0815 
[email protected]

Singapore, April 10, 2025 (GLOBE NEWSWIRE) — SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced the launch of its latest innovation in robotics – brand-named Orion, a multi-functional robot equipped with real-time security surveillance, on-demand digital concierge support, and intelligent spot cleaning and sweeping capabilities. SIMPPLE’s Orion robot made its official debut at Kings Club, Melbourne. The private launch event, which takes place today and tomorrow, was jointly facilitated by Melbourne-based property management firm Above OCM and technology integrator Australian Robot Technology. Clients and partners of Above OCM and Australian Robot Technology were invited to witness the launch of SIMPPLE’s multi-functional robots (Gemini and Orion) in Australia.

“With increasing pressure for buildings to become safer, smarter, and more environmentally friendly, the development and launch of Orion could not be more timely. Today’s announcement underscores our commitment to innovation in the field of service robotics, delivering fit-for-purpose robotic solutions that enhance operational efficiency and cover multi-faceted integrated capabilities,” said SIMPPLE chief executive officer Norman Schroeder. “Like Gemini, Orion is the next evolution in autonomous building operations and fits well into the range of SIMPPLE Robotics line-up.”

The new Orion robot combines intelligence and safety, equipped with advanced dual compute modules housed within its modular head and robot body, delivering powerful Artificial Intelligence (A.I.) performance across both security surveillance and cleaning functions. It can also operate independently or integrate seamlessly with existing CCTV systems, allowing facilities to extend their surveillance coverage while reducing operational costs. Through its 32-beam 3D LiDAR and precision navigation, Orion can operate effectively in high-density areas while performing a variety of functions to support building service operators.

“After extensive global research, including significant time spent in Singapore studying SIMPPLE’s advanced technological capabilities, we together with Australian Robot Technology are proud to be part of the launch of Gemini and Orion robots in Australia,” said Simon Saint-John, Director of Above OCM. “Being able to integrate different facility functions and technology assets on a single platform like SIMPPLE is amazing. We see tremendous benefits deploying such robotic solutions in residential settings, to complement our staff and promote a cleaner and more secure environment for us all in Melbourne.”

According to Norman, “Being supported by Above OCM and Australian Robot Technology to launch our revolutionary multi-functional robots in Australia is definitely a meaningful milestone for us to showcase our innovative technologies in Australia and represents an exciting step in our international expansion with forward-thinking industry stakeholders to help them achieve their goals through A.I. robotics and automation.”

Today’s announcement follows the Company’s release on October 16, 2024, detailing the launch and sale of 3-in-1 multifunctional Gemini robots for Singapore, Malaysia, and Thailand markets aggregating $1.0 million.

About SIMPPLE LTD.

Headquartered in Singapore, SIMPPLE LTD. is an advanced technology solution provider in the emerging PropTech space, focused on helping facilities owners and managers manage facilities autonomously. Founded in 2016, the Company has a strong foothold in the Singapore facilities management market, serving over 60 clients in both the public and private sectors and extending out of Singapore into Australia and the Middle East. The Company has developed its proprietary SIMPPLE Ecosystem, to create an automated workforce management tool for building maintenance, surveillance and cleaning comprised of a mix of software and hardware solutions such as robotics (both cleaning and security) and Internet-of-Things (“IoT”) devices. 

For more information on SIMPPLE, please visit: https://www.simpple.ai

Safe Harbor Statement

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”) today announced that its Board of Directors has authorized a share repurchase program under which the Company may purchase up to $1,000,000 of its outstanding common stock. The Directors believe that the market price of its common stock trades at prices that do not reflect their underlying value.

Under the program, Conduit may repurchase shares from time to time through open market transactions or other methods in compliance with SEC Rule 10b-18. Purchases will be executed by The Benchmark Company, the Company’s appointed broker, and will be subject to market conditions, corporate liquidity requirements, regulatory considerations, and other factors.

The share repurchase program does not obligate the Company to acquire a particular amount of common stock and the Company will use its discretion to repurchase shares. The program has no fixed expiration date and may be adjusted or terminated at any time by the Company.

“Given the current market value of our common stock we believe it is prudent to have the option to re-purchase our shares using our existing cash reserves,” said Dr. David Tapolczay, Chief Executive Officer of Conduit. “With multiple milestones anticipated across our pipeline this year, including preclinical data readouts and Phase II trial initiation for AZD1656, we believe in a balanced approach to capital allocation.”

About Conduit Pharmaceuticals

Conduit is a multi-asset clinical stage, life science company delivering an efficient model for compound development. Conduit both acquires and funds the development of Phase 2-ready assets, building an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics, and seeking an exit through third-party license deals following successful clinical trials. Led by a highly experienced team of pharmaceutical executives including Dr. David Tapolczay and Dr. Freda Lewis-Hall, this novel approach is a departure from the traditional pharma/biotech business model of taking assets through regulatory approval.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding Conduit’s future results of operations and financial position, Conduit’s business strategy, prospective product candidates, product approvals, research and development costs, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated studies and business endeavors with third parties, and future results of current and anticipated product candidates, are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to; the inability to maintain the listing of Conduit’s securities on Nasdaq; the ability to recognize the anticipated benefits of the business combination completed in September 2023, which may be affected by, among other things, competition; the ability of the combined company to grow and manage growth economically and hire and retain key employees; the risks that Conduit’s product candidates in development fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable authorities on a timely basis or at all; changes in applicable laws or regulations; the possibility that Conduit may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties to be identified in the proxy statement/prospectus (as amended and supplemented) relating to the business combination completed in September 2023, including those under “Risk Factors” therein, and in other filings made by Conduit with the U.S. Securities and Exchange Commission. Moreover, Conduit operates in a very competitive and rapidly changing environment. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond Conduit’s control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and except as required by law, Conduit assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Conduit gives no assurance that it will achieve its expectations.

Investors & Media:

[email protected]